Novavax Analyst 'Encouraged' By Preclinical Data For Coronavirus Vaccine Candidate

Novavax Analyst 'Encouraged' By Preclinical Data For Coronavirus Vaccine Candidate

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Novavax, Inc.’s (NASDAQ: NVAX) presentation at the International Society for Vaccines virtual congress Tuesday has increased Cantor Fitzgerald’s confidence in its investigational coronavirus vaccine, codenamed NVX-CoV2373.” data-reactid=”19″>Novavax, Inc.’s (NASDAQ: NVAX) presentation at the International Society for Vaccines virtual congress Tuesday has increased Cantor Fitzgerald’s confidence in its investigational coronavirus vaccine, codenamed NVX-CoV2373.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The Novavax Analyst: Charles Duncan reiterated an Overweight rating and $148 price target for Novavax.” data-reactid=”20″>The Novavax Analyst: Charles Duncan reiterated an Overweight rating and $148 price target for Novavax.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The Novavax Thesis: Preclinical data detailed by Novavax at the congress were encouraging, Duncan said.” data-reactid=”21″>The Novavax Thesis: Preclinical data detailed by Novavax at the congress were encouraging, Duncan said.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The key new information, according to the analyst, was that cynomolgus macaques — a non-human primate — vaccinated with NVXCoV2373 and challenged with live virus showed lower levels of detectable viral loads in bronchoalveolar lavage samples compared to placebo animals.” data-reactid=”22″>The key new information, according to the analyst, was that cynomolgus macaques — a non-human primate — vaccinated with NVXCoV2373 and challenged with live virus showed lower levels of detectable viral loads in bronchoalveolar lavage samples compared to placebo animals.

This suggested that the vaccine helps reduce viral replication/load.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Benzinga is covering every angle of how the coronavirus affects the financial world.&nbsp;For daily updates,&nbsp;sign up for our coronavirus newsletter.” data-reactid=”24″>Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.

The analyst also noted nasal swabs from infected macaques showed there is a several log reduction in viral load in the vaccinated group as compared to the placebo group.

“We continue to be encouraged as a result of these preclinical data that provide a window into potential translatability into human efficacy, assuming that immune functionality is conserved from these non-human to human primates,” Duncan wrote in the note.

If immune functionality works in human primates, the incremental preclinical data would further support the rationale for moving forward in human clinical trials, Duncan said.

Cantor remains focused on the initial immunogenicity data from the Phase 1 study due in July.

That Novavax’ sPhase 1 study has enrolled a slightly higher number of participants compared to other coronavirus vaccine studies is a positive, the firm said.

In the Phase 1 update, it will look for IgG response against the spike protein, neutralizing antibody response and T-cell response, which will likely help establish a high-level perspective on the breadth and depth of the overall immune response.

Latest Ratings for NVAX

Date Firm Action From To
Jul 2020 HC Wainwright & Co. Maintains Buy
Jul 2020 Ladenburg Thalmann Downgrades Buy Neutral
Jun 2020 B. Riley FBR Maintains Buy

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="View More Analyst Ratings for NVAX
View the Latest Analyst Ratings” data-reactid=”34″>View More Analyst Ratings for NVAX
View the Latest Analyst Ratings

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="See more from Benzinga” data-reactid=”35″>See more from Benzinga

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.” data-reactid=”39″>© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a Reply

Your email address will not be published. Required fields are marked *